Skip to content

McKesson MCK Return on equity

Discontinued — last reported Q2 '21

Return on equity at other companies

Eli Lilly logo
Eli LillyLLY
107.6%+29.9pp
Cencora logo
CencoraCOR
130.6%-99.8pp
Viatris logo
ViatrisVTRS
-2%-0.9pp
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
4.6%-1.3pp
CVS Health logo
CVS HealthCVS
3.8%-3.2pp
Merck & Co. logo
Merck & Co.MRK
19%-20.3pp

Other financials

Income statement

See full
Revenue$96.3B+6.0%
Gross profit$4.0B+11.1%
Operating income$2.2B+35.1%
Net income$1.7B+33.5%
EPS (diluted)$13.65+37.6%

Balance sheet

See full
Cash & equivalents$4.0B-33.3%
Total debt$2.3B-74.2%
Total equity-$2.2B-4.7%
Total assets$82.3B+9.6%

Cash flow

See full
Operating cash flow$3.4B-55.9%
CapEx$111.0M-34.3%
Free cash flow$3.3B-56.3%

Valuation

See full
Market cap$91.3B+25.7%
Enterprise value$89.6B+19.6%
P/E19.2×-2.9×
P/S0.2×0.0×

Profitability

See full
Gross margin3.6%-0.1pp
Operating margin1.5%+0.3pp
Net margin1.2%+0.3pp

Returns & leverage

See full
Debt / equity
Current ratio0.9×0.0×

Where this comes from

Calculated from McKesson’s reported figures.

Based on trailing twelve months.

The official record: McKesson’s 10-Q, filed November 2, 2021, on SEC EDGAR. View the filing →

Questions, answered.

What does return on equity mean?
How much profit the company earns on the money shareholders have invested.
How do you interpret return on equity?
Higher is better, but very high ROE can be manufactured by leverage — a thin equity base inflates the ratio. Read it next to debt-to-equity and ROIC to tell genuine returns from balance-sheet engineering.
How does return on equity compare across companies?
Comparable across peers, with the leverage caveat. Negative or near-zero equity makes ROE meaningless, so it is suppressed there.